Bleeding outcomes were similar across groups.<h4>Conclusion</h4>Clopidogrel is less effective in patients with CYP2C19 LoF genotype and cardiovascular disease, minor stroke, or TIA. This evidence concerns the gene CYP2C19 and cardiovascular disorder.